Case Report: Dramatic response to amivantamab plus chemotherapy in EGFR G719A–mutant lung adenocarcinoma with liver and peritoneal metastases - Quiz - MDSpire

Case Report: Dramatic response to amivantamab plus chemotherapy in EGFR G719A–mutant lung adenocarcinoma with liver and peritoneal metastases

  • By

  • Jiwon Kim

  • Han Gyeol Kim

  • Seung Hyeun Lee

  • May 26, 2026

  • 0 min

Share

Original Source(s)

Case Report: Dramatic response to amivantamab plus chemotherapy in EGFR G719A–mutant lung adenocarcinoma with liver and peritoneal metastases

  • by Jiwon Kim, Han Gyeol Kim, Seung Hyeun Lee

  • May 26, 2026

Related Content

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report